Compare QURE & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QURE | KEN |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | Netherlands | Singapore |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2013 | 2014 |
| Metric | QURE | KEN |
|---|---|---|
| Price | $51.05 | $66.66 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 15.0K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 4.39% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | N/A |
| Revenue Next Year | $200.43 | N/A |
| P/E Ratio | ★ N/A | $9.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $41.50 |
| 52 Week High | $71.50 | $95.93 |
| Indicator | QURE | KEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.03 | 50.29 |
| Support Level | $39.50 | $64.41 |
| Resistance Level | $50.47 | $71.05 |
| Average True Range (ATR) | 1.94 | 1.16 |
| MACD | 0.05 | 0.24 |
| Stochastic Oscillator | 82.59 | 60.79 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.